Archive for the ‘IDIBAPS’ Category

Categories

Posted in:

Tuesday March 21st, 2017

An International study proves that Huntington’s disease alters neurons since they start developing

 

Huntington’s disease could alter neurons since they start developing, according to a study conducted by the international HD iPSC Consortium, which counts with the participation of the team of the Laboratory of Stem Cells and Regenerative Medicine of the Department of Biomedicine of the Faculty of Medicine and Health Sciences of the UB, led by Josep M. Canals, from the Faculty of Medicine and Health Sciences of the University of Barcelona and the August Pi i Sunyer Biomedical Research Institute (IDIBAPS). The study, published in the scientific journal Nature Neuroscience, counts with the collaboration of the experts of the UB Mónica Pardo, Gerardo García, Marco Straccia, Phil Sanders and Jordi Alberch. Read the rest of this entry »

Categories

Posted in:

Thursday March 16th, 2017

IDIBAPS and IRB Barcelona researchers create viruses to selectively attack tumor cells

Scientists at the IDIBAPS Biomedical Research Institute and at the Institute for Research in Biomedicine (IRB Barcelona) lead a study in which they have designed a new strategy to get genetically modified viruses to selectively attack tumor cells without affecting  healthy tissues. The study, published today by the journal Nature Communications, is part of Eneko Villanueva’s work for his PhD and it is co-lead by Cristina Fillat, head of the Gene Therapy and Cancer Group at IDIBAPS, and Raúl Méndez, ICREA researcher at IRB Barcelona. Read the rest of this entry »

Categories

Posted in:

Tuesday March 07th, 2017

The European project LifeBrain will analyze the keys of cognitive ageing with data from more than 6.000 people

The European project LifeBrain has been set up this year. This is a project funded with ten million euros by the European Union program Horizon 2020, and which will last five years, aiming to identify risk and protective factors in the brain and mental health during different life stages. The project counts with the participation of fourteen research groups from different European countries –mainly Scandinavian- coordinated by the University of Oslo. The only group representing southern Europe is led by David Bartrés Faz, researcher from the Institute of Neurosciences of the University of Barcelona and IDIBAPS and coordinator of the Barcelona Brain Stimulaiton Lab (BBSLab). Read the rest of this entry »

Categories

Posted in:

Friday February 17th, 2017

PhD4MD Programme is launched to bring research closer to clinical practice

The Centre for Genomic Regulation (CRG), the August Pi i Sunyer Biomedical Research Institute (IDIBAPS), the Institute for Research in Biomedicine (IRB Barcelona) and the Vall d’Hebron Research Institute  (VHIR) launch the third year of the training programme “PhD for Medical Doctors – PhD4MD”. Read the rest of this entry »

Comments Closed

A therapeutic HIV vaccine clinical trial induces viral control in 5 people without taking antiretroviral therapy

A therapeutic HIV vaccine clinical trial showed, for the first time, that in some cases the immune system of HIV infected people can be reeducated to control the virus for long periods without taking antiretroviral treatment. In particular, 5 out of 13 participants who stopped treatment (38.5%) have been controlling the virus for 5, 13, 17, 20 and 27 weeks, respectively. The study, still ongoing, is conducted in Barcelona and tests a vaccine developed by researchers at Oxford University in combination with a drug, romidepsin, able to awaken latent viruses in the body. The study is conducted by IrsiCaixa and the Fight AIDS Foundation and performed at the ospital Clínic de Barcelona-IDIBAPS, the Germans Trias i Pujol University Hospital (Barcelona) and the community center BCN Checkpoint. Read the rest of this entry »

Comments Closed
Wednesday February 15th, 2017

IDIBAPS participates in an European project to enable personalized therapies in multiple sclerosis

A global partnership, coordinated by the Karolinska Institutet and in which IDIBAPS researchers participate, has received 15 million euros from the European Commission framework program Horizon2020 to find new and improved treatments for Multiple Sclerosis (MS). This project, named MultipleMS, involves universities and companies from 12 European countries and the USA, which will join efforts to adapt the development and application of therapies to each MS patient.

Read the rest of this entry »

Comments Closed
Page 1 of 7412345...Last »